T-cell Therapy Market Report by Modality (Research, Commercialized), Therapy Type (CAR T-Cell based, T Cell Receptor (TCR) based, Tumor Infiltrating Lymphocytes (TIL) Based), Indication (Hematologic Malignancies, Solid Tumors, and Others), and Region 2024-2032

T-cell Therapy Market Report by Modality (Research, Commercialized), Therapy Type (CAR T-Cell based, T Cell Receptor (TCR) based, Tumor Infiltrating Lymphocytes (TIL) Based), Indication (Hematologic Malignancies, Solid Tumors, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A3750
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global T-cell Therapy Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Modality
    6.1    Research
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Commercialized
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Therapy Type
    7.1    CAR T-cell based
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    T Cell Receptor (TCR) based
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Tumor Infiltrating Lymphocytes (TIL) based
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Indication
    8.1    Hematologic Malignancies
        8.1.1 Market Trends
        8.1.2 Key Segments
           8.1.2.1 Lymphoma
           8.1.2.2 Leukemia
           8.1.2.3 Myeloma
        8.1.3 Market Forecast
    8.2    Solid Tumors
        8.2.1 Market Trends
        8.2.2 Key Segments
           8.2.2.1 Melanoma
           8.2.2.2 Brain and Central Nervous System
           8.2.2.3 Liver Cancer
           8.2.2.4 Others
        8.2.3 Market Forecast
    8.3   Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Amgen Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Aurora Biopharma Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    bluebird bio Inc
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Bristol-Myers Squibb Company
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Fate Therapeutics
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Gilead Sciences Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Merck KGaA
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Mustang Bio Inc. (Fortress Biotech Inc.)
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
        14.3.9    Novartis AG
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Pfizer Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Sorrento Therapeutics Inc.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
        14.3.12    TCR2 Therapeutics
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials

List of Figures

Figure 1: Global: T-cell Therapy Market: Major Drivers and Challenges
Figure 2: Global: T-cell Therapy Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: T-cell Therapy Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: T-cell Therapy Market: Breakup by Modality (in %), 2023
Figure 5: Global: T-cell Therapy Market: Breakup by Therapy Type (in %), 2023
Figure 6: Global: T-cell Therapy Market: Breakup by Indication (in %), 2023
Figure 7: Global: T-cell Therapy Market: Breakup by Region (in %), 2023
Figure 8: Global: T-cell Therapy (Research) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: T-cell Therapy (Research) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: T-cell Therapy (Commercialized) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: T-cell Therapy (Commercialized) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: T-cell Therapy (CAR T-cell based) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: T-cell Therapy (CAR T-cell based) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: T-cell Therapy (T Cell Receptor-TCR based) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: T-cell Therapy (T Cell Receptor-TCR based) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: T-cell Therapy (Tumor Infiltrating Lymphocytes-TIL based) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: T-cell Therapy (Tumor Infiltrating Lymphocytes-TIL based) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: T-cell Therapy (Hematologic Malignancies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: T-cell Therapy (Hematologic Malignancies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: T-cell Therapy (Solid Tumors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: T-cell Therapy (Solid Tumors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: T-cell Therapy (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: T-cell Therapy (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: North America: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: North America: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: United States: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: United States: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Canada: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Canada: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Asia-Pacific: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Asia-Pacific: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: China: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: China: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Japan: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Japan: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: India: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: India: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: South Korea: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: South Korea: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Australia: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Australia: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Indonesia: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Indonesia: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Others: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Others: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Europe: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Europe: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Germany: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Germany: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: France: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: France: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: United Kingdom: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: United Kingdom: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Italy: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Italy: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Spain: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Spain: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Russia: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Russia: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Latin America: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Latin America: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Brazil: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Brazil: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Mexico: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Mexico: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Middle East and Africa: T-cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Middle East and Africa: T-cell Therapy Market: Breakup by Country (in %), 2023
Figure 72: Middle East and Africa: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Global: T-cell Therapy Industry: SWOT Analysis
Figure 74: Global: T-cell Therapy Industry: Value Chain Analysis
Figure 75: Global: T-cell Therapy Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: T-cell Therapy Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: T-cell Therapy Market Forecast: Breakup by Modality (in Million US$), 2024-2032
Table 3: Global: T-cell Therapy Market Forecast: Breakup by Therapy Type (in Million US$), 2024-2032
Table 4: Global: T-cell Therapy Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 5: Global: T-cell Therapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: T-cell Therapy Market: Competitive Structure
Table 7: Global: T-cell Therapy Market: Key Players

T-cell Therapy Market Report by Modality (Research, Commercialized), Therapy Type (CAR T-Cell based, T Cell Receptor (TCR) based, Tumor Infiltrating Lymphocytes (TIL) Based), Indication (Hematologic Malignancies, Solid Tumors, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More